Tech Transfer eNews Blog

How COVID-19 has influenced commercialization at Emory University


By Jesse Schwartz
Published: October 20th, 2021

In a recent blog post, Todd Sherer, executive director of the Office of Technology Transfer (OTT) at Emory University, discusses the impact of the COVID-19 pandemic on tech commercialization at the university.

“It has torn down some of the traditional and conventional thinking around timeline and investments,” says Sherer. “We realize now that things can — and should — move faster.”

Although the pandemic came with some financial challenges, Sherer says there were also record levels of funds available from the federal government to help accelerate innovation, especially in the development of new therapeutics and diagnostics that addressed COVID-19.

Looking forward, Sherer hopes the positive results of this approach will influence the way tech transfer is supported on a broad scale.

“It is maddening that all life-saving therapies don’t move as fast as the COVID therapies,” he says.

According to Sherer, there are countless other diseases that could benefit from the kinds of accelerated funding and timelines applied during the pandemic. “It is imperative that we find new solutions for them too,” he says.

Source: Emory Technology Transfer Blog

Posted under: Tech Transfer e-News